EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,866,000 | +5.0% | 42,911 | +20.9% | 0.01% | 0.0% |
| Q3 2021 | $1,777,000 | -24.3% | 35,502 | -4.7% | 0.01% | -36.4% |
| Q2 2021 | $2,347,000 | -54.9% | 37,259 | -33.5% | 0.01% | -59.3% |
| Q1 2021 | $5,202,000 | -11.5% | 55,998 | -14.7% | 0.03% | -20.6% |
| Q4 2020 | $5,881,000 | +44.0% | 65,629 | +66.0% | 0.03% | +30.8% |
| Q3 2020 | $4,085,000 | +25.6% | 39,532 | -3.9% | 0.03% | +18.2% |
| Q2 2020 | $3,252,000 | +6.9% | 41,121 | -21.8% | 0.02% | -12.0% |
| Q1 2020 | $3,042,000 | +81.7% | 52,574 | +69.4% | 0.02% | +108.3% |
| Q4 2019 | $1,674,000 | -35.6% | 31,036 | -37.6% | 0.01% | -42.9% |
| Q3 2019 | $2,599,000 | +21.8% | 49,727 | +12.6% | 0.02% | +23.5% |
| Q2 2019 | $2,133,000 | +10.3% | 44,150 | +15.3% | 0.02% | 0.0% |
| Q1 2019 | $1,933,000 | – | 38,276 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
| Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
| AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
| Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
| Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
| SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
| EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
| PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |